journal
https://read.qxmd.com/read/38629237/post-covid-anxiety-depression-and-quality-of-life-among-egyptian-hemodialysis-patients
#1
JOURNAL ARTICLE
Rehab AlSayed Shaban, Ahmed E Abdulgalil, Ahmed Bahie
INTRODUCTION: This study examined the impact of Coronavirus disease 2019  on anxiety, depression, and health-related quality of life (HRQOL) among Egyptian hemodialysis (HD) patients. METHODS: This multicenter cross-sectional study was carried out in Egypt in the years 2021-2022, where 300 HD patients from four HD centers were allocated into two groups: post-COVID and non-COVID. The Hospital Anxiety and Depression Scale (HADS) and the Kidney Disease QOL-36 questionnaire were used to assess anxiety, depression, and QOL of the included patients...
April 17, 2024: Therapeutic Apheresis and Dialysis
https://read.qxmd.com/read/38572624/effect-of-medium-cut-off-membranes-on-pentosidine-and-n-carboxymethyl-lysine-levels-in-uncontrolled-diabetic-hemodialysis-patients
#2
JOURNAL ARTICLE
Neriman Sıla Koç, Hasan Yeter, Tolga Yıldırım, Yunus Erdem, Rahmi Yılmaz
INTRODUCTION: Patients on hemodialysis, especially with diabetes, face elevated cardiovascular events. A major contributor to complications associated with diabetes is advanced glycation end products (AGEs). Removing these compounds is challenging in traditional hemodialysis. Medium-cut-off (MCO) membranes potentially remove toxins without significant albumin loss. This study explored how MCO membranes impact AGEs levels in uncontrolled diabetic patients undergoing hemodialysis. METHODS: Sixteen patients received MCO membrane dialysis, while others used high-flux (HF) membranes...
April 4, 2024: Therapeutic Apheresis and Dialysis
https://read.qxmd.com/read/38545743/a-meta-analysis-of-risk-factors-for-acute-kidney-injury-in-pneumonia-effectiveness-of-nursing-interventions
#3
REVIEW
Liangjuan Yuan, Arshad Mehmood, Lei Meng
INTRODUCTION: The spread of coronavirus disease 2019 (COVID-19) worldwide since November 2019 is of interest to understand its impact on various organs. COVID-19 patients experience a higher incidence of acute kidney injury (AKI) compared with non-COVID-19 patients. METHODS: A systematic literature search was conducted that covered the period from November 1, 2019 to February 28, 2021. RESULTS: The analysis incorporated a comprehensive review of 19 studies of 21 362 patients...
March 28, 2024: Therapeutic Apheresis and Dialysis
https://read.qxmd.com/read/38504452/active-vitamin-d-analog-and-sars-cov-2-igg-after-bnt162b2-vaccination-in-patients-with-hemodialysis
#4
JOURNAL ARTICLE
Akio Nakashima, Izumi Yamamoto, Arisa Kobayashi, Keita Kimura, Tatsuhiro Yaginuma, Shinichiro Nishio, Kazuhiko Kato, Rena Kawai, Tetsuya Horino, Ichiro Ohkido, Takashi Yokoo
INTRODUCTION: Vaccination is the effective strategy for coronavirus disease 2019 (COVID-19). However, few studies have investigated the association between severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) immunoglobulin (Ig)G and vitamin D. METHODS: This study aimed to investigate the association between SARS-CoV-2 IgG and active vitamin D analogs in hemodialysis patients. Blood samples were collected four times: before vaccination and 30, 60, and 90 days after vaccination, BNT162b2 (Pfizer©)...
March 19, 2024: Therapeutic Apheresis and Dialysis
https://read.qxmd.com/read/38499495/calcimimetics-treatment-strategy-for-serum-calcium-and-phosphate-management-in-patients-with-secondary-hyperparathyroidism-undergoing-dialysis-a-systematic-review-and-meta-analysis-of-randomized-studies
#5
JOURNAL ARTICLE
Kentaro Nakai, Keiji Kono, Shunsuke Yamada, Masatomo Taniguchi, Takayuki Hamano, Masafumi Fukagawa
INTRODUCTION: Several calcimimetics, other than cinacalcet, are commercially available; however, their effects on calcium and phosphate levels have not yet been fully studied. We conducted a systematic review and meta-analysis of randomized controlled trials to evaluate the impact of calcimimetics on the management of serum calcium and phosphate levels in patients with secondary hyperparathyroidism undergoing dialysis. METHODS: A systematic literature search through October 2023 and a meta-analysis were conducted on the effects of upacicalcet, etelcalcetide, evocalcet, and cinacalcet on serum calcium and phosphate levels in patients with secondary hyperparathyroidism undergoing dialysis; we searched PubMed, Ovid MEDLINE, and the Cochrane Central Register of Controlled Trials, and 21 studies comprising 6371 patients undergoing dialysis were included...
March 18, 2024: Therapeutic Apheresis and Dialysis
https://read.qxmd.com/read/38471811/successful-treatment-with-granulocyte-and-monocyte-adsorption-apheresis-for-plaque-type-skin-lesions-in-patients-with-psoriatic-arthritis
#6
JOURNAL ARTICLE
Mariko Seishima, Hideki Hachiken, Takuma Furukawa, Junichiro Yamamoto
INTRODUCTION: Granulocyte and monocyte adsorption apheresis (GMA) is usually performed weekly for refractory skin diseases, such as generalized pustular psoriasis and psoriatic arthritis (PsA). METHODS: Four patients with PsA who were refractory to previous treatments were enrolled. They received five or ten sessions of GMA. We assessed the clinical conditions of each patient and laboratory findings before and after GMA. RESULTS: GMA was effective in plaque-type skin eruptions in all four patients with PsA...
March 12, 2024: Therapeutic Apheresis and Dialysis
https://read.qxmd.com/read/38471797/effect-of-aspirin-on-cardiovascular-events-in-patients-undergoing-hemodialysis-with-hyperphosphatemia-a-post-hoc-analysis-of-the-landmark-trial
#7
JOURNAL ARTICLE
Masanori Kato, Hidetoshi Ito, Akane Yamakawa, Tatsuo Kagimura, Masafumi Fukagawa, Masahiro Yamamoto, Yoshinori Saito, Tadao Akizawa, Hiroaki Ogata
INTRODUCTION: The clinical benefits of aspirin in patients undergoing hemodialysis remain unclear. METHODS: The secondary analysis of the LANDMARK trial investigated whether aspirin use was associated with cardiovascular events (CVEs) and all-cause mortality was performed. A total of 2135 patients at risk for vascular calcification were analyzed using a Cox proportional hazards model with propensity score matching. RESULTS: The risk of CVEs was comparable between participants with aspirin use at baseline and those without at baseline, between participants with aspirin use during the study period and those without during the study period, and between participants with new aspirin prescription and those without aspirin use during the study period...
March 12, 2024: Therapeutic Apheresis and Dialysis
https://read.qxmd.com/read/38462749/associations-of-vitamin-d-receptor-activators-and-calcimimetics-with-falls-and-effect-modifications-by-physical-activity-a-prospective-cohort-study-on-the-japan-dialysis-outcomes-and-practice-patterns-study
#8
JOURNAL ARTICLE
Miho Murashima, Ryohei Yamamoto, Eiichiro Kanda, Noriaki Kurita, Hisashi Noma, Takayuki Hamano, Masafumi Fukagawa
INTRODUCTION: This study aimed to examine the associations of vitamin D receptor activators (VDRA) and calcimimetics use with falls. METHODS: This is a prospective cohort study on hemodialysis patients in the Japan Dialysis Outcomes and Practice Patterns Study. We excluded those who were unable to walk. The associations of VDRA or calcimimetics use with falls and effect modifications by physical activity were analyzed using marginal structural models. RESULTS: In total, 1875 patients were included...
March 10, 2024: Therapeutic Apheresis and Dialysis
https://read.qxmd.com/read/38462734/a-global-assessment-of-hemostatic-function-of-healthy-allogeneic-stem-cell-donors-undergoing-apheresis-by-rotational-thromboelastometry
#9
JOURNAL ARTICLE
Neslihan Cilek, Elif Ugurel, Ozgur Can Eren, Ozlem Yalcin, Olga Meltem Akay
INTRODUCTION: Peripheral blood stem cell (PBSC) collection via apheresis requires the administration of granulocyte colony-stimulating factor (filgrastim) to stem cell donors. Several reports have shown that filgrastim administration and apheresis procedure induce a hypercoagulable state across PBSC collection, which might predispose certain donors to thrombotic complications. METHODS: We evaluated the hemostatic functions of healthy allogeneic stem cell donors by rotational thromboelastometry (ROTEM)...
March 10, 2024: Therapeutic Apheresis and Dialysis
https://read.qxmd.com/read/38456251/the-44th-annual-meeting-of-the-japanese-society-for-apheresis
#10
EDITORIAL
Takaya Abe
No abstract text is available yet for this article.
March 8, 2024: Therapeutic Apheresis and Dialysis
https://read.qxmd.com/read/38453633/investigation-of-treatment-volume-versus-circulating-blood-volume-during-rheocarna-treatment
#11
JOURNAL ARTICLE
Yuki Hoshikawa, Atsushi Ohkubo, Takatoshi Sakurasawa, Mana Usui, Masaya Deushi, Hiroko Yamamoto, Shotaro Naito
INTRODUCTION: Rheocarna's therapeutic effect is associated with fibrinogen (Fib) and low-density lipoprotein cholesterol (LDL-C) adsorptive removal. This study aimed to retrospectively investigate the association between treatment volume (TV) and circulating blood volume (CBV) and the Fib removal rate (Fib-RR) and LDL-C-RR. METHODS: CBV and TV/CBV, cut-off value (CO value), and area under the receiver operating characteristic (ROC) curve (AUC) were calculated. The Fib-RR and LDL-C-RR at the midterm and end of treatment were compared...
March 7, 2024: Therapeutic Apheresis and Dialysis
https://read.qxmd.com/read/38448284/a-retrospective-study-describing-the-effective-exchange-of-total-blood-plasma-for-disease-control-in-the-exacerbation-of-serpiginous-choroiditis
#12
JOURNAL ARTICLE
Yuri Katayama, Daisuke Katagiri, Takuya Harada, Kanako Terakawa, Keiki Shimada, Emi Sakamoto, Takahito Niikura, Minami Suzuki, Yuki Yoshizaki, Naoto Nunose, Motohiko Sato, Shigeko Yashiro, Hiroshi Kaneko, Hideki Takano
INTRODUCTION: Serpiginous choroiditis presents with large yellow-white exudative lesions that occur near the optic nerve papillae, that progresses slowly with repeated relapses and cures. Although infection and autoimmunity have been implicated, the cause is unknown. METHODS: A man was diagnosed with serpiginous choroiditis on clinical and other examinations. He started treatment with oral corticosteroids, cyclophosphamide, adalimumab, azathioprine, rituximab, and mycophenolate mofetil...
March 6, 2024: Therapeutic Apheresis and Dialysis
https://read.qxmd.com/read/38444376/development-and-validation-of-a-nomogram-model-for-accurately-predicting-severe-fatigue-in-maintenance-hemodialysis-patients-a-multicenter-cross-sectional-study-in-china
#13
JOURNAL ARTICLE
Xinyuan Zhou, Jiahui Han, Fuxiang Zhu
INTRODUCTION: This study aims to analyze the risk factors for severe fatigue in maintenance hemodialysis (MHD) patients and develop a clinical prediction model to help doctors and patients prevent severe fatigue. METHODS: Multicentre MHD patients were included in this study. The objective was to investigate the risk factors for severe fatigue in MHD patients and develop a prediction model. RESULTS: A total of 243 MHD patients were included in the study, and the incidence of severe fatigue was found to be 20...
March 6, 2024: Therapeutic Apheresis and Dialysis
https://read.qxmd.com/read/38438272/upregulation-of-low-density-lipoprotein-receptor-activity-in-steroid-resistant-nephrotic-syndrome-treated-with-low-density-lipoprotein-apheresis-clinical-efficacy-and-potential-mechanism
#14
LETTER
https://read.qxmd.com/read/38409916/utilizing-triple-tandem-extracorporeal-membrane-oxygenation-therapeutic-plasma-exchange-and-continuous-renal-replacement-therapy-in-a-neonate-with-elevated-plasma-free-hemoglobin
#15
LETTER
Senan Hadid, Jay S Raval
No abstract text is available yet for this article.
February 26, 2024: Therapeutic Apheresis and Dialysis
https://read.qxmd.com/read/38385762/changes-in-antibody-titer-after-four-and-five-doses-of-the-sars-cov-2-vaccine-in-japanese-post-kidney-transplant-patients
#16
JOURNAL ARTICLE
Kumiko Fujieda, Akihito Tanaka, Ryosuke Kikuchi, Nami Takai, Shoji Saito, Yoshinari Yasuda, Yuta Sano, Masashi Kato, Kazuhiro Furuhashi, Shoichi Maruyama
INTRODUCTION: Immunosuppressed patients exhibit low antibody acquisition rates following severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination. Kidney transplant recipients previously exhibited low antibody acquisition rates after two vaccine doses, which increased after the third dose. We evaluated antibody titers of Japanese post-kidney transplant patients after the fourth and fifth vaccinations. METHODS: Antibody titers for SARS-CoV-2 spike protein were measured between 3 weeks and 3 months after the fourth or fifth vaccination...
February 22, 2024: Therapeutic Apheresis and Dialysis
https://read.qxmd.com/read/38369912/blood-at-the-end-of-tunnel-rare-complication-of-tunneled-cuff-catheter
#17
LETTER
Asheesh Kumar, Samriti Gupta, Naresh Chauhan
No abstract text is available yet for this article.
February 19, 2024: Therapeutic Apheresis and Dialysis
https://read.qxmd.com/read/38351539/clinical-implication-of-ivabradine-therapy-in-patients-receiving-hemodialysis
#18
LETTER
Naoya Kataoka, Teruhiko Imamura
No abstract text is available yet for this article.
February 13, 2024: Therapeutic Apheresis and Dialysis
https://read.qxmd.com/read/38317412/removal-of-inflammatory-factors-and-prognosis-of-patients-with-septic-shock-complicated-with-acute-kidney-injury-by-hemodiafiltration-combined-with-ha330-ii-hemoperfusion
#19
JOURNAL ARTICLE
Juan Zhou, Haopeng Li, Lei Zhang, Guangjian Chen, Gang Wang, HuiHui Zhu, Yingxin Hao, Gang Wu
INTRODUCTION: To explore the effect of CRRT using CVVHDF + HP on the removal of inflammatory mediators in patients with septic shock complicated with AKI. METHODS: A total of 20 patients between January 1, 2018, and December 31, 2021, were included. The patients were randomly divided into the treatment group (CVVHDF + HP) and the control group (CVVHDF). Changes in inflammatory factors, including IL-1β, IL-6, IL-8, TNF-α, PCT, and CRP were compared...
February 5, 2024: Therapeutic Apheresis and Dialysis
https://read.qxmd.com/read/38316625/potential-risks-of-cell-free-concentrated-ascites-reinfusion-therapy-in-tafro-syndrome-patient
#20
LETTER
Kasumi Satoh, Manabu Okuyama, Hajime Nakae
No abstract text is available yet for this article.
February 5, 2024: Therapeutic Apheresis and Dialysis
journal
journal
40470
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.